The half-life directly affects: Dosing frequency Longer half-lives allow less frequent administration Therapeutic stability Extended duration maintains consistent drug levels Patient compliance Weekly dosing improves adherence compared to daily injections Retatrutide exemplifies this principle
These days, theres a clear shift toward foods that offer more than just a quick fix: snacks that keep you full, steady your energy, and actually taste good
Interestingly, the STEP-8 study 22 revealed a higher incidence of psychiatric events with liraglutide 3 mg (15.0%) compared to semaglutide 2.4 mg (5.6%) and placebo (10.6%)
Results revealed that RGC was significantly higher (5.4%) in patients with T2DM on GLP-1 RAs (semaglutide, liraglutide, and dulaglutide) compared to 0.49% in patients without T2DM on GLP-1 RAs ( p -value 0.004) [17]
Some people struggle to eat enough of anything, let alone hit aggressive protein targets
Even in patients who did not lose significant weight, inflammatory markers dropped